Clinical Trial Update: A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describing a chemoimmunotherapy study for men with metastatic prostate cancer, including neuroendocrine and aggressive-variant d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Neuroendocrine Carcinoma

Snippet

Sponsor: Andrew J. Armstrong, MD | Conditions: Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING